I Heras
Overview
Explore the profile of I Heras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Douglass G, Arriola A, Heras I, Martin G, Le Coarer E, Gross S, et al.
Opt Express
. 2018 Aug;
26(14):18470-18479.
PMID: 30114026
With the growing complexity of astronomical instruments devoted to interferometry, such as MATISSE (a 4 telescope beam combiner) or FIRST (a 9 sub-apertures beam combiner), and the rebirth of space...
2.
Kwon M, Bautista G, Balsalobre P, Sanchez-Ortega I, Montesinos P, Bermudez A, et al.
Bone Marrow Transplant
. 2017 Mar;
52(8):1138-1143.
PMID: 28346415
For patients with AML, the best alternative donor remains to be defined. We analyze outcomes of patients who underwent myeloablative umbilical cord blood or haploidentical hemopoietic stem cell transplantation (HSCT)...
3.
Gayoso J, Balsalobre P, Pascual M, Castilla-Llorente C, Lopez-Corral L, Kwon M, et al.
Bone Marrow Transplant
. 2016 May;
51(10):1307-1312.
PMID: 27159177
Relapsed or refractory Hodgkin lymphoma (advanced HL) still remains a therapeutic challenge. Recently, unmanipulated haploidentical related donor transplant with reduced conditioning regimen (HAPLO-RIC) and post-transplant cyclophosphamide (PT-Cy) as GvHD prophylaxis...
4.
Diaz-Beya M, Brunet S, Nomdedeu J, Cordeiro A, Tormo M, Escoda L, et al.
Blood Cancer J
. 2015 Oct;
5:e352.
PMID: 26430723
Acute myeloid leukemia (AML) is a heterogeneous disease whose prognosis is mainly related to the biological risk conferred by cytogenetics and molecular profiling. In elderly patients (⩾60 years) with normal...
5.
Martino R, Bautista G, Parody R, Garcia I, Esquirol A, Rovira M, et al.
Transpl Infect Dis
. 2015 Feb;
17(2):221-33.
PMID: 25652036
Background: Umbilical cord blood transplantation (CBT) is an established alternative source of stem cells in the setting of unrelated transplantation. When compared with other sources, single-unit CBT (sCBT) is associated...
6.
Fox M, Barba P, Heras I, Lopez-Parra M, Gonzalez-Vicent M, de la Camara R, et al.
Clin Microbiol Infect
. 2015 Feb;
21(1):e1-3.
PMID: 25636943
No abstract available.
7.
Parody R, Martino R, de la Camara R, Garcia-Noblejas A, Esquirol A, Garcia-Cadenas I, et al.
Bone Marrow Transplant
. 2014 Oct;
50(2):274-81.
PMID: 25347007
Umbilical cord blood (CB) is increasingly used as an alternative source of stem cells in adult unrelated transplantation. Although registry studies report similar overall outcomes in comparison with BM/PB, comparative...
8.
Diaz-Beya M, Brunet S, Nomdedeu J, Tejero R, Diaz T, Pratcorona M, et al.
Leukemia
. 2013 Sep;
28(4):804-12.
PMID: 24072101
Acute myeloid leukemia (AML) is a heterogeneous disease, and optimal treatment varies according to cytogenetic risk factors and molecular markers. Several studies have demonstrated the prognostic importance of microRNAs (miRNAs)...
9.
Nomdedeu J, Hoyos M, Carricondo M, Bussaglia E, Estivill C, Esteve J, et al.
Leukemia
. 2013 Apr;
27(11):2157-64.
PMID: 23584566
We retrospectively assessed whether normalized bone marrow WT1 levels could be used for risk stratification in a consecutive series of 584 acute myeloid leukemia (AML) patients. A cutoff value of...
10.
Llorente A, Perez-Valero I, Garcia E, Heras I, Fraile V, Garcia P, et al.
Enferm Infecc Microbiol Clin
. 2011 Feb;
29(4):263-8.
PMID: 21330008
Aim: To investigate mortality risk factors in patients with zygomycosis. Patients And Methods: Retrospective case history review of patients diagnosed with proven zygomicosis in 17 centres in Spain. We compared...